The Readout Loud

350 Episodo

1. Episode 49: Painkiller racketeering, the limits of genetic tests, and pharma's day on the Hill

   Publicado: 21/2/2019
2. Episode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH

   Publicado: 14/2/2019
3. Episode 47: A bad day for bold biotech, campaign 2020, and where do drugs come from?

   Publicado: 7/2/2019
4. Episode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns

   Publicado: 31/1/2019
5. Episode 45: CRISPR upheaval, Celgene's chutzpah, and canine genomics

   Publicado: 24/1/2019
6. Episode 44: FDA furloughs, '80s pop radio, and video game therapeutics

   Publicado: 17/1/2019
7. Episode 43: A people's history of J.P. Morgan

   Publicado: 10/1/2019
8. Episode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring

   Publicado: 3/1/2019
9. Episode 41: Watson's latest stumble, a glimpse into the crystal ball, and revisiting Sarepta

   Publicado: 20/12/2018
10. Episode 40: Gilead’s new boss, the year that was, and the thing about DNA tests

    Publicado: 13/12/2018
11. Episode 39: Using the word 'cure,' an FDA loophole, & making biotech history

    Publicado: 6/12/2018
12. Episode 38: Your guide to the #CRISPRbabies controversy

    Publicado: 29/11/2018
13. Episode 37: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts

    Publicado: 15/11/2018
14. Episode 36: What the midterms mean, a golden age on hold, and the $4 million drug

    Publicado: 8/11/2018
15. Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence

    Publicado: 1/11/2018
16. Episode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma

    Publicado: 25/10/2018
17. Episode 33: Drug prices on TV, immortal blockbusters, and genetic privacy

    Publicado: 18/10/2018
18. Episode 32: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn

    Publicado: 11/10/2018
19. Episode 31: Nobel snubs, millenial founders, and a new kind of lightning round

    Publicado: 4/10/2018
20. Episode 30: A fish oil epiphany, VC monopolies and ketamine clinics

    Publicado: 27/9/2018